Fate Therapeutics, Inc.
News
Fate Therapeutics to Present at 2024 Cantor Global Healthcare Conference
Globe Newswire SAN DIEGO, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced...\n more…
Fate Therapeutics, Inc. (NASDAQ:FATE) Position Increased by Acadian Asset Management LLC
Ticker Report Acadian Asset Management LLC lifted its position in Fate Therapeutics, Inc. (NASDAQ:FATE - Free Report) by 17.2% during the 2nd quarter, according to the company in its most recent disclosure with...\n more…
Ausdal Financial Partners Inc. Takes Position in Fate Therapeutics, Inc. (NASDAQ:FATE)
Ticker Report Ausdal Financial Partners Inc. purchased a new stake in Fate Therapeutics, Inc. (NASDAQ:FATE - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC...\n more…
Ausdal Financial Partners Inc. Acquires New Shares in Fate Therapeutics, Inc. (NASDAQ:FATE)
Zolmax Ausdal Financial Partners Inc. acquired a new stake in Fate Therapeutics, Inc. (NASDAQ:FATE - Free Report) during the second quarter, according to its most recent filing with the Securities and...\n more…
Fate Therapeutics Strengthens Legal Safeguards for Leadership
TipRanks Financial Blog Fate Therapeutics (FATE) has issued an update. Fate Therapeutics, Inc. has updated its indemnification agreements for directors and officers, enhancing legal protec...\n more…
